Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | STK17A |
| Upstream (Parents) |
|---|
| (<<) ANKDD1A → STK17A |
| (<<) ARHGAP25 → STK17A |
| (<<) CASP4 → STK17A |
| (<<) CCND2 → STK17A |
| (<<) CYP2U1 → STK17A |
| (<<) GRK5 → STK17A |
| (<<) HOPX → STK17A |
| (<<) IL18 → STK17A |
| (<<) INPP5D → STK17A |
| (<<) KIAA1949 → STK17A |
| (<<) KYNU → STK17A |
| (<<) LPXN → STK17A |
| (<<) LTB → STK17A |
| (<<) PPP3CC → STK17A |
| (<<) PRKCB → STK17A |
| (<<) PRKCH → STK17A |
| (<<) RASSF5 → STK17A |
| (<<) SRC → STK17A |
| (<<) STAT4 → STK17A |
| (<<) VAV1 → STK17A |
| Downstream (Children) |
|---|
| STK17A → ARL4C (>>) |
| STK17A → CD83 (>>) |
| STK17A → CEACAM1 (>>) |
| STK17A → DLX2 (>>) |
| STK17A → GBP2 (>>) |
| STK17A → HSD11B1 (>>) |
| STK17A → ITPR2 (>>) |
| STK17A → PAG1 (>>) |
| STK17A → PIP4K2A (>>) |
| STK17A → PITPNC1 (>>) |
| STK17A → RORA (>>) |
| STK17A → STK17B (>>) |
| STK17A → TCF4 (>>) |
| STK17A → TEX10 (>>) |
| STK17A → TRERF1 (>>) |
